‘We just need someone who’s not crazy’: Inside the White House decision to nominate Erica Schwartz as CDC director

‘We just need someone who’s not crazy’: Inside the White House decision to nominate Erica Schwartz as CDC director

The past year has been marked by turmoil at the Centers for Disease Control and Prevention, with events such as a deadly shooting, frequent leadership changes, and a decline in public confidence in the agency’s role as a trusted health authority. These challenges led the Trump administration to prioritize a single key criterion when selecting a new director. “We just need someone who’s not crazy,” said a White House official to CNN, highlighting the focus on mental stability amid a chaotic environment.

After months of deliberation, officials announced their choice: Erica Schwartz, a retired US Coast Guard officer and former deputy surgeon general. Her selection signals a shift from the administration’s previous approach, which favored candidates aligned with the “Make America Healthy Again” platform. Unlike earlier contenders, Schwartz has a proven track record in managing vaccination initiatives and responding to public health crises, offering a contrast to the first nominee, whose vaccine hesitancy led to his withdrawal.

The move has sparked mixed reactions. While some on Capitol Hill have praised Schwartz’s qualifications, others remain skeptical, particularly within the medical freedom movement. “She’s a good and well-qualified nominee, and would be in any administration,” noted Dr. Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security. “However, the issue is not her qualifications — it’s the environment she’s expected to navigate.”

“The White House isn’t even trying to win the midterms at this point,” said Toby Rogers, a prominent vaccine critic, reacting to Schwartz’s appointment. “This is a slap in the face to the medical freedom base that gave Trump the presidency in 2016 and 2024.”

Following the confirmation of Dr. Susan Monarez, a scientist and experienced public health official, her tenure was short-lived due to conflicts with Robert F. Kennedy Jr. and his efforts to reshape vaccine policies. Monarez was removed less than a month into her role, prompting the administration to consider interim leadership under Jim O’Neill, who was criticized for lacking engagement with the CDC’s Atlanta headquarters and poor communication skills.

Currently, Jay Bhattacharya, who also leads the National Institutes of Health, serves as acting director. The White House has been increasingly concerned about the HHS department’s internal instability and the potential impact of Kennedy’s agenda on Republican prospects in the midterms. This urgency is reflected in the focus on repositioning health messaging to align more closely with populist themes, as seen in the early stages of HHS budget hearings.